Wendy J. Levin

20.1k total citations · 2 hit papers
36 papers, 15.8k citations indexed

About

Wendy J. Levin is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wendy J. Levin has authored 36 papers receiving a total of 15.8k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wendy J. Levin's work include Cerebral Palsy and Movement Disorders (6 papers), HER2/EGFR in Cancer Research (5 papers) and Hedgehog Signaling Pathway Studies (5 papers). Wendy J. Levin is often cited by papers focused on Cerebral Palsy and Movement Disorders (6 papers), HER2/EGFR in Cancer Research (5 papers) and Hedgehog Signaling Pathway Studies (5 papers). Wendy J. Levin collaborates with scholars based in United States, United Kingdom and Italy. Wendy J. Levin's co-authors include Dennis J. Slamon, Axel Ullrich, Steven Wong, William McGuire, Gary M. Clark, Michael F. Press, William Godolphin, Lovell A. Jones, Susan G. Stuart and Duane E. Keith and has published in prestigious journals such as Science, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Wendy J. Levin

34 papers receiving 15.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogene

1987 9.3k citations Dennis J. Slamon, Steven Wong et al. Science profile →
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer

1989 5.7k citations Dennis J. Slamon, William Godolphin et al. Science profile →

Peers

Countries citing papers authored by Wendy J. Levin

Since Specialization

Citations

This map shows the geographic impact of Wendy J. Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy J. Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy J. Levin more than expected).

Fields of papers citing papers by Wendy J. Levin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy J. Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy J. Levin. The network helps show where Wendy J. Levin may publish in the future.

Co-authorship network of co-authors of Wendy J. Levin

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy J. Levin. A scholar is included among the top collaborators of Wendy J. Levin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy J. Levin. Wendy J. Levin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 5573: Validation of Aspyre Clinical Test for Lung at low input levels: Simplified genomic profiling for NSCLC with minimal tissue requirements 2025 ·Cancer Research ·(unknown), Katherine Knudsen, (unknown), Rebecca Palmer, (unknown), Ryan Evans, Eleanor R. Gray, (unknown), Robert J. Osborne, (unknown), Wendy J. Levin, (unknown)	0
2	The use and perception of support walkers for children with disabilities: a United Kingdom survey 2020 ·BMC Pediatrics ·(unknown), Wendy J. Levin, Jennifer Ryan	9
3	Validity of the International Physical Activity Questionnaire Short Form (IPAQ-SF) as a measure of physical activity (PA) in young people with cerebral palsy: A cross-sectional study 2019 ·Physiotherapy ·Grace Lavelle, Marika Noorkõiv, Nicola Theis, Thomas Korff, Cherry Kilbride, Vasilios Baltzopoulos, Adam Shortland, Wendy J. Levin, Jennifer Ryan	38
4	Strength Training for Adolescents with cerebral palsy (STAR): study protocol of a randomised controlled trial to determine the feasibility, acceptability and efficacy of resistance training for adolescents with cerebral palsy 2016 ·BMJ Open ·Jennifer Ryan, Nicola Theis, Cherry Kilbride, Vasilios Baltzopoulos, Charlotte Waugh, Adam Shortland, Grace Lavelle, Marika Noorkõiv, Wendy J. Levin, Thomas Korff	18
5	Perspectives from man’s best friend: National Academy of Medicine’s Workshop on Comparative Oncology 2016 ·Science Translational Medicine ·Amy K. LeBlanc, Matthew Breen, Peter L. Choyke, Mark W. Dewhirst, Timothy M. Fan, Daniel L. Gustafson, Lee J. Helman, Michael B. Kastan, Deborah W. Knapp, Wendy J. Levin, Cheryl A. London, Nicola J. Mason, Christina Mazcko, Patricia N. Olson, Rodney L. Page, Beverly A. Teicher, Douglas H. Thamm, Jeffrey M. Trent, David M. Vail, Chand Khanna	118
6	Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics study 2015 ·The Lancet Haematology ·Giovanni Martinelli, Vivian G. Oehler, Cristina Papayannidis, Rachel Courtney, M. Naveed Shaik, Xiaoxi Zhang, Ashleigh O’Connell, Karen R. McLachlan, Xianxian Zheng, Jerald P. Radich, Michele Baccarani, Hagop M. Kantarjian, Wendy J. Levin, Jörge E. Cortes, Catriona Jamieson	97
7	Ex Vivo Modulation of Donor Cells Results in Enhanced Survival and Reduced Gvhd Mortality 2015 ·Blood ·(unknown), (unknown), Leah Mitchell, (unknown), (unknown), Thuy Le, (unknown), (unknown), Betsy Rezner, David Robbins, Wendy J. Levin, Daniel Shoemaker	2
8	A Phase I Study of PF-04449913, an Oral Hedgehog Inhibitor, in Patients with Advanced Solid Tumors 2014 ·Clinical Cancer Research ·Andrew J. Wagner, Wells A. Messersmith, M. Naveed Shaik, Sherry Li, Xianxian Zheng, Karen R. McLachlan, Rossano Cesari, Rachel Courtney, Wendy J. Levin, Anthony B. El-Khoueiry	61
9	Evaluation of the effect of food and ketoconazole on the pharmacokinetics of the smoothened inhibitor PF-04449913 in healthy volunteers 2014 ·Cancer Chemotherapy and Pharmacology ·M. Naveed Shaik, Robert R. LaBadie, Dan Rudin, Wendy J. Levin	30
10	Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial 2013 ·Annals of Oncology ·Michael A. Gordon, Holly Gundacker, Jacqueline Benedetti, J. S. Macdonald, Joaquina Baranda, Wendy J. Levin, Charles D. Blanke, Wafaa Elatre, (unknown), Jian Zhou, Heinz‐Josef Lenz, Michael F. Press	68
11	Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial. 2012 ·Journal of Clinical Oncology ·Michael A. Gordon, Holly Gundacker, Jacqueline Benedetti, John S. Macdonald, Joaquina Baranda, Wendy J. Levin, Charles D. Blanke, Wafaa Elatre, (unknown), Heinz‐Josef Lenz, Michael F. Press	1
12	Phase 1 Dose-Escalation Study of PF-04449913, An Oral Hedgehog (Hh) Inhibitor, in Patients with Select Hematologic Malignancies 2011 ·Blood ·Catriona Jamieson, Jörge E. Cortes, Vivian G. Oehler, Michele Baccarani, Hagop M. Kantarjian, Cristina Papayannidis, (unknown), Xiaoxi Zhang, M. Naveed Shaik, Rachel Courtney, Wendy J. Levin, Giovanni Martinelli	45
13	Phase I study of PF-03446962, a fully human mab against ALK 1, a TGFβ receptor involved in tumor angiogenesis. 2010 ·Journal of Clinical Oncology ·Laura W. Goff, Filippo de Braud, Richard B. Cohen, (unknown), Cristina Noberasco, Hossein Borghaei, (unknown), (unknown), Wendy J. Levin, Corrado Gallo‐Stampino	11
14	Analysis of expression of TGF-β1 receptor (ALK-1) in normal and tumor tissues by tissue microarrays 2009 ·Journal of Clinical Oncology ·Andreas Erbersdobler, Ronald Simon, Olaf Hellwinkel, Carsten Bokemeyer, Guido Sauter, Dana D. Hu‐Lowe, Wendy J. Levin, Corrado Gallo‐Stampino, Walter Fiedler	1
15	The murine eosinophil peroxidase gene (Epx) maps to chromosome 11 1997 ·Mammalian Genome ·Karen L. Denzler, Wendy J. Levin, James J. Lee, Nancy A. Lee	8
16	The murine eosinophil major basic protein gene (Prg2) maps to chromosome 2 1997 ·Mammalian Genome ·Karen L. Denzler, Wendy J. Levin, Polly A. Quiram, N. A. Lee, J. J. Lee	3
17	Bispecific humanized anti-IL-2 receptor alpha beta antibodies inhibitory for both IL-2- and IL-15-mediated proliferation 1997 ·The Journal of Immunology ·(unknown), Wendy J. Levin, Bhupesh B. Desai, Linda M. Reik, P. Y. Lin, (unknown), (unknown), J. Yun Tso, (unknown), J Hakimi	9
18	Preparation of a Bispecific F(ab') ₂ Targeted to the Human IL-2 Receptor 1995 ·Journal of Hematotherapy ·J. Yun Tso, (unknown), Wendy J. Levin, J Hakimi	12
19	Tumor Suppressor and Immediate Early Transcription Factor Genes in Non-small Cell Lung Cancer 1994 ·CHEST Journal ·Wendy J. Levin, Graham Casey, (unknown), (unknown), Peter T. Reissmann, Dennis J. Slamon	12
20	Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer breakdown → 1989 ·Science ·Dennis J. Slamon, William Godolphin, Lovell A. Jones, John A. Holt, Steven Wong, Duane E. Keith, Wendy J. Levin, Susan G. Stuart, (unknown), Axel Ullrich, Michael F. Press	5668

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact